1.1.1 D-2-Bromolysergic acid diethylamide

Page 1

Reaxys

PubChem

Reactions (4)

Substances (1)

Citations (34)

Structure

N° of preparations All Preps | All Reactions

Structure/Compound Data Chemical Name: 2-bromo-lysergide Reaxys Registry Number: 46871

CAS Registry Number: 478-84-2 Type of Substance: heterocyclic Molecular Formula: C20H24BrN3O Linear Structure Formula: C20H24BrN3O Molecular Weight: 402.334 InChI Key: VKRAXSZEDRWLAG-SJKOYZFVSA-N

1

2 prep out of 4 reactions.

Synthesize | Hide Details Find similar Chemical Names and Synonyms 2-bromo-lysergide, Bromolysergide, 2-bromo-5R,8R-lysergic acid diethyl amide, 2-bromo-6-methyl-9,10-didehydro-ergoline-8-carboxylic acid diethylamide, (5R,8R)2-bromo-lysergic acid diethyl amide Identification Substance Label (1) Label

Reference

2; R&1%=H,R&2%=Br,R...

Stanovnik, Branko; Tisler, Miha; Jurgec, Milan; Rucman, Rudolf

Heterocycles, 1981 , vol. 16, # 5 p. 741 - 745 Title/Abstract Full Text Show Details

Derivative (1) Comment (Derivative)

Reference

Available Data

N° of ref.

Identification Physical Data (5) Spectra (5) Bioactivity (4)

34


Troxler; Hofmann

Helvetica Chimica Acta, 1957 , vol. 40, p. 2160,2169 Full Text Show Details

Lg-hydrogentartrate (mp: 130-140 degree ; <alpha>=34 degree ) Further Data see Handbook

Physical Data Melting Point (1) Melting Point

Solvent (Melting Point)

Reference

120 - 127 °C

diethyl ether

Troxler; Hofmann

Helvetica Chimica Acta, 1957 , vol. 40, p. 2160,2169 Full Text Show Details

Optical Rotatory Power (4) Type (Optical Rotatory Power)

Concentration (Optical Rotatory Power)

Solvent (Optical Rotatory Power)

Optical Rotatory Power

Wavelength (Optical Rotatory Power)

Temperature (Optical Rotatory Power)

Reference Sandoz Ltd.

Patent: US4609731 A1, 1986 ; Title/Abstract Full Text Show Details

[alpha]

1 g/100ml

pyridine

17 deg

589 nm

20 °C

Stanovnik, Branko; Tisler, Miha; Jurgec, Milan; Rucman, Rudolf

Heterocycles, 1981 , vol. 16, # 5 p. 741 - 745 Title/Abstract Full Text Show Details

[alpha]

c=0.5

CHCl3

53 deg

589 nm

20 °C

Troxler; Hofmann

Helvetica Chimica Acta, 1957 , vol. 40, p. 2160,2169 Full Text Show Details

[alpha]

c=0.5

pyridine

15 deg

589 nm

20 °C

Troxler; Hofmann

Helvetica Chimica Acta, 1957 , vol. 40, p. 2160,2169 Full Text Show Details

Spectra IR Spectroscopy (1) Description (IR Spectroscopy)

Solvent (IR Spectroscopy)

Comment (IR Spectroscopy)

Reference

Spectrum

nujol

3500 - 650 cm**(-1)

Troxler; Hofmann

Helvetica Chimica Acta, 1957 , vol. 40, p. 2160,2169 Full Text Show Details

UV/VIS Spectroscopy (2) Description (UV/VIS Spectroscopy)

Solvent (UV/VIS Spectroscopy)

Comment (UV/VIS Spectroscopy)

Bowd et al.

Journal of the Chemical Society [Section] B: Physical Organic, 1971 , p. 1509 Full Text View citing articles Show Details

Absorption maxima

Spectrum

Reference

ethanol

210 - 350 nm

Troxler; Hofmann

Helvetica Chimica Acta, 1957 , vol. 40, p. 2160,2169 Full Text Show Details

Fluorescence Spectroscopy (1) Description (Fluorescence Spectroscopy)

Solvent (Fluorescence Spectroscopy)

Comment (Fluorescence Spectroscopy)

Reference

Maxima

H2O

460 nm in Loesung vom pH 1.

Udenfriend et al.

Journal of Pharmacology and Experimental Therapeutics, 1957 ,


vol. 120, p. 26,29 Full Text Show Details

Phosphorescence Spectroscopy (1) Description (Phosphorescence Spectroscopy)

Reference

Phosphorescence

Bowd et al.

Journal of the Chemical Society [Section] B: Physical Organic, 1971 , p. 1509 Full Text View citing articles Show Details

Bioactivity Pharmacological Data (4) 1 of 4

Comment (Pharmacological Data)

Bioactivities present

Reference

Sibley, David R.; Monsma JR., Frederick J.; Hamblin, Mark

Patent: US2002/91235 A1, 2002 ; Title/Abstract Full Text Show Details

Troxler; Hofmann

Helvetica Chimica Acta, 1957 , vol. 40, p. 2160,2169 Full Text Show Details

Udenfriend et al.

Journal of Pharmacology and Experimental Therapeutics, 1957 , vol. 120, p. 26,29 Full Text Show Details

Bowd et al.

Journal of the Chemical Society [Section] B: Physical Organic, 1971 , p. 1509 Full Text View citing articles Show Details

Stanovnik, Branko; Tisler, Miha; Jurgec, Milan; Rucman, Rudolf

Heterocycles, 1981 , vol. 16, # 5 p. 741 - 745 Title/Abstract Full Text Show Details

Lopez-Rodriguez, Maria L.; Porras, Esther; Benhamu, Bellinda; Ramos, Jose. A.; Morcillo, M. Jose; Lavandera, Jose L.

Bioorganic and Medicinal Chemistry Letters, 2000 , vol. 10, # 10 p. 1097 - 1100 Title/Abstract Full Text View citing articles Show Details

Nagasaki, Tohru; Sakai, Katsunori; Segawa, Masaharu; Katsuyama, Yoshihiko; Haga, Nobuhiro; Koike, Masahiro; Kawada, Kenji; Takechi, Shozo

Journal of Labelled Compounds and Radiopharmaceuticals, 2001 , vol. 44, # 14 p. 993 - 1004 Title/Abstract Full Text Show Details

Ebersole, Barbara J.; Visiers, Irache; Weinstein, Harel; Sealfon, Stuart C.

Molecular Pharmacology, 2003 , vol. 63, # 1 p. 36 - 43 Title/Abstract Full Text View citing articles Show Details

Glennon, Richard A.

Journal of Medicinal Chemistry, 2003 , vol. 46, # 14 p. 2795 - 2812 Title/Abstract Full Text View citing articles Show Details

Lopez-Rodriguez, Maria L.; Porras, Esther; Morcillo, M. Jose; Benhamu, Bellinda; Soto, Luis J.; Lavandera, Jose L.; Ramos, Jose A.; Olivella, Mireia; Campillo, Mercedes; Pardo, Leonardo

Journal of Medicinal Chemistry, 2003 , vol. 46, # 26 p. 5638 - 5650 Title/Abstract Full Text View citing articles Show Details

Berg, Kelly A.; Stout, Brian D.; Cropper, Jodie D.; Maayani, Saul; Clarke, William P.

Molecular Pharmacology, 1999 , vol. 55, # 5 p. 863 - 872 Title/Abstract Full Text View citing articles Show Details

Guang, Wei; Wang, Hongyan; Su, Tao; Weinstein, I. Bernard; Jia, Bei Wang

Molecular Pharmacology, 2004 , vol. 66, # 5 p. 1285 - 1292 Title/Abstract Full Text View citing articles Show Details

Kolaczkowski, Marcin; Nowak, Mateusz; Pawlowski, Maciej; Bojarski, Andrzej J.

Journal of Medicinal Chemistry, 2006 , vol. 49, # 23 p. 6732 - 6741 Title/Abstract Full Text View citing articles Show Details

Sandoz Ltd.

Patent: US4609731 A1, 1986 ; Title/Abstract Full Text Show Details

Burt; Creese; Snyder

Molecular pharmacology, 1976 , vol. 12, # 5 p. 800 - 812 Title/Abstract Full Text Show Details

Bennett Jr; Snyder

Molecular Pharmacology, 1976 , vol. 12, # 3 p. 373 - 389 Title/Abstract Full Text View citing articles Show Details

Lovell; Freedman

Molecular Pharmacology, 1976 , vol. 12, # 4 p. 620 - 630 Title/Abstract Full Text View citing articles Show Details

Green; Johnson; Weinstein; Maayani

Proceedings of the National Academy of Sciences of the United States of America, 1977 , vol. 74, # 12 p. 5697 - 5701 Title/Abstract Full Text View citing articles Show Details

Leopoldo

Current Medicinal Chemistry, 2004 , vol. 11, # 5 p. 629 - 661 Title/Abstract Full Text View citing articles Show Details

Bard; Zgombick; Adham; Vaysse; Branchek; Weinshank

Journal of Biological Chemistry, 1993 , vol. 268, # 31 p. 23422 - 23426


Title/Abstract Full Text Show Details

2 of 4

Comment (Pharmacological Data)

Bioactivities present

Reference

Monsma Jr.; Shen; Ward; Hamblin; Sibley

Molecular Pharmacology, 1993 , vol. 43, # 3 p. 320 - 327 Title/Abstract Full Text Show Details

Wainscott; Cohen; Schenck; Audia; Nissen; Baez; Kursar; Lucaites; Nelson

Molecular Pharmacology, 1993 , vol. 43, # 3 p. 419 - 426 Title/Abstract Full Text Show Details

Perry

The Journal of pharmacology and experimental therapeutics, 1986 , vol. 236, # 2 p. 548 - 559 Title/Abstract Full Text Show Details

Weiss; Drummond

Molecular Pharmacology, 1981 , vol. 20, # 3 p. 592 - 597 Title/Abstract Full Text View citing articles Show Details

Peroutka; Snyder

Molecular Pharmacology, 1979 , vol. 16, # 3 p. 687 - 699 Title/Abstract Full Text View citing articles Show Details

Northup; Mansour

Molecular Pharmacology, 1978 , vol. 14, # 5 p. 804 - 819 Title/Abstract Full Text View citing articles Show Details

Bard, Jonathan A.; Branchek, Theresa; Weinshank, Richard L.

Patent: US2003/166066 A1, 2003 ; Title/Abstract Full Text Show Details

Sibley, David R.; Monsma, Frederick J.; Hamblin, Mark

Patent: US2002/91235 A1, 2002 ; Title/Abstract Full Text Show Details

vol. AD27768 Full Text Show Details

HARRIS ISBELL; E. J. MINER; C. R. L0GAN

Psychopharmacology, 1959 , vol. 1, p. 20 - 28 Full Text Show Details

LASZLO GYERMEK

Journal of medicinal chemistry, 1964 , vol. 7, # 3 p. 280 - 284 Title/Abstract Full Text View citing articles Show Details

Full Text Show Details

ROTHLIN E.

Annals of the New York Academy of Sciences, 1957 , vol. 66, # 3 p. 668 - 676 Full Text Show Details

M.L. Lopez-Rodriguez; B. Benhamu; M.J. Morcillo; E. Porras; J.L. Lavandera; L. Pardo Current Medicinal Chemistry: Central Nervous System Agents, 2004 , vol. 4, # 3 p. 203 - 214 Title/Abstract Full Text Show Details

3 of 4

4 of 4

Effect (Pharmacological Data)

receptor systems; effect on

Species or TestSystem (Pharmacological Data)

CHO-1C19 cells expressing human 5-HT2C receptors

Concentration (Pharmacological Data)

700 nmol/l

Method (Pharmacological Data)

cells labeled with <3H>AA (4 h) and <3H>-myo-inositol (24 h); labeled cells incubated with title comp. for 24 h; IP accumulation in response to 1 μmol/l DOI (10 min, 37 deg C) determined

Further Details (Pharmacological Data)

CHO-1C19: Chinese hamster ovary K1 cells "low" expressing human 5-HT2C receptors (about 250 fmol/mg); DOI: (+/-)-1-(2,5-dimethoxy4-iodophenyl)-2-aminopropane, 5-HT2C (serotonin) agonist; AA: arachidonic acid; IP: inositol phosphate; vehicle control

Results

title comp. increased DOI-mediated IP accumulation acting as inverse agonist (diagram)

Reference

Berg, Kelly A.; Stout, Brian D.; Cropper, Jodie D.; Maayani, Saul; Clarke, William P.

Molecular Pharmacology, 1999 , vol. 55, # 5 p. 863 - 872 Title/Abstract Full Text View citing articles Show Details

Effect (Pharmacological Data)

receptor systems; effect on

Species or TestSystem (Pharmacological Data)

CHO-1C7 cells expressing human 5-HT2C receptors

Concentration

700 nmol/l


(Pharmacological Data) Method (Pharmacological Data)

cells labeled with <3H>AA (4 h) and <3H>-myo-inositol (24 h); labeled cells incubated in medium with title comp. at 37 deg C for 25 min in the presence of 20 mmol/l LiCl and 0.1 percent BSA; AA release and IP accumulation determined

Further Details (Pharmacological Data)

CHO-1C7: Chinese hamster ovary K1 cells "high" expressing human 5-HT2C receptors (about 5-10 pmol/mg); 5-HT: serotonin; AA: arachidonic acid; IP: inositol phosphate; vehicle control

Comment (Pharmacological Data)

No effect

Reference

Berg, Kelly A.; Stout, Brian D.; Cropper, Jodie D.; Maayani, Saul; Clarke, William P.

Molecular Pharmacology, 1999 , vol. 55, # 5 p. 863 - 872 Title/Abstract Full Text View citing articles Show Details


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.